Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612403/ |